Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
CymaBay Therapeutics Comments on Engine Capital Director Nominations ...
CymaBay Initiates IDEAL, a Phase 3 Placebo-Controlled, Randomized Study ...
Medtech Alert on LinkedIn: CymaBay Therapeutics Announces Publication ...
CymaBay Therapeutics on LinkedIn: #tlm23 #primarybiliarycholangitis # ...
CymaBay Therapeutics on LinkedIn: #primarybiliarycholangitis # ...
CymaBay Therapeutics on LinkedIn: #livercancer #liverawarenessmonth # ...
#cymabayway #primarybiliarycholangitis #pbc | CymaBay Therapeutics
Congrats to our portfolio company CymaBay Therapeutics on their ...
Gilead Sciences Enhances Liver Portfolio Through Acquisition of CymaBay ...
CymaBay Announces FDA Acceptance of NDA and Priority Review for ...
#hiring #nowhiring #biopharma #careers #newjob #recruitment | CymaBay ...
CymaBay Therapeutics on LinkedIn: #pbc #liverdisease #raredisease # ...
Cymabay Therapeutics | The Org
CymaBay Announces an Oral Presentation of Seladelpar Phase 3 Pivotal ...
CymaBay submits New Drug Application for PBC treatment
CymaBay Therapeutics on LinkedIn: #donatelifemonth #donatelife #pbc # ...
CymaBay laser focused on seladelpar pivotal trial for PBC - BioTuesdays
CymaBay addresses primary biliary cholangitis | CymaBay Therapeutics ...
CymaBay Therapeutics on LinkedIn: #acg2023 #primarybiliarycholangitis # ...
CymaBay Therapeutics on LinkedIn: #rarediseaseday #lightupforrare #pbc ...
CymaBay Therapeutics on LinkedIn: #nationalcaregiversmonth # ...
CymaBay Therapeutics on LinkedIn: #primarybiliarycholangitis #pbc # ...
CymaBay announces data from RESPONSE trial of seladelpar for primary ...
CymaBay Therapeutics Presents Positive Final Results From 52-Week Phase ...
Gilead Sciences announces the acquisition of CymaBay Therapeutics ...
CymaBay continues to stay committed to improving the lives of patients ...
#primarybiliarycholangitis #pbc #liverdisease #hepatology | CymaBay ...
Gilead to buy liver disease specialist CymaBay for $4.3bn | pharmaphorum
CymaBay Therapeutics on LinkedIn: #hiring #biopharma #nowhiring #jobs
CymaBay Therapeutics on LinkedIn: #pbc #pbc #liverdisease #raredisease ...
HistoIndex and CymaBay Therapeutics Team Up to Advance NASH Drug ...
#pbc #liverdisease #raredisease #hepatology | CymaBay Therapeutics
BIOTECH (89) Cymabay Therapeutics: Seladelpar, an oral, selective ...
Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay ...
How is Gilead's acquisition of CymaBay expected to influence the market
Acquiring CymaBay Therapeutics gives Gilead Sciences another drug for ...
CymaBay Therapeutics
#companyculture #advocacy #culture | CymaBay Therapeutics
CymaBay Therapeutics on LinkedIn: #tbt #rarediseaseday #pbc # ...
After Setbacks, CymaBay Pushes Forward with Potential Liver Disease ...
Ben Kozub CymaBay Therapeutics Measuring Quality of Life in People With ...
#pride2023 #inclusivity #dei #lgbtqia #equalitymatters | CymaBay ...
CymaBay Therapeutics’ $4.3 Billion Acquisition by Gilead Sciences ...
CymaBay Therapeutics on LinkedIn: #hiring #nowhiring #biopharma # ...
#newlook #cymabayway | CymaBay Therapeutics
Primary Biliary Cholangitis (PBC)... - CymaBay Therapeutics
Gilead acquires CymaBay for US$ 4.3 billion; Exscientia sacks founder ...
107 - CymaBay Sets to Massively Improve Outcomes in PBC Patients ...
Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay ...
CymaBay Therapeutics on LinkedIn: #pbcawarenessmonth #ddw2022 #pbc # ...
Gilead Buys CymaBay for $4.3 Billion - What It Means for Liver Disease ...
Gilead to Acquire CymaBay for $4.3B, Adding to Liver Portfolio
CymaBay Therapeutics on LinkedIn: #liverawarenessmonth #liverdisease
Gilead To Acquire CymaBay Therapeutics For $4.3B
Seladelpar from CymaBay Reaches Significant Statistical Levels for ...
Gilead Sciences Buys CymaBay Therapeutics for $4.3B, Boosting Liver
CymaBay Therapeutics on LinkedIn: #womenshealthmonth #pbc #liverdisease ...
Jeff Fordham on LinkedIn: It's a done deal: CymaBay Therapeutics, Inc.
Gilead Sciences to Acquire CymaBay Therapeutics for $4.3 Billion
Gilead to buy CymaBay for $4.3 billion in bets on liver disease treatment
CymaBay Therapeutics - AnnualReports.com
Gilead Sciences to Acquire CymaBay Therapeutics in $4.3 Billion Deal ...
CymaBay Therapeutics on LinkedIn: #leadership #healthcare #raredisease
Working at CymaBay Therapeutics | Glassdoor
CymaBay Therapeutics on LinkedIn: #hiring #nowhiring #biopharma
#easlcongress #hepatology #primarybiliarycholangitis #liverdisease # ...
MHRA (UK) approves seladelpar (Livdelzi) to treat primary biliary ...
#primarybiliarycholangitis #pbcawarenessmonth #chronicdisease # ...
#primarybiliarycholangitis #pbc #hepatology #liverdisease #phase3study ...
#easlcongress #primarybiliarycholangitis #pbc #liverdisease #hepatology ...
Gilead adquiere CymaBay, enf. del hígado - Pharmabiz.NET
43亿美元！吉利德收购Cymabay Therapeutics - 药时代DrugTimes
#primarybiliarycholangitis #phase3study #liverdisease #hepatology ...
CymaBay's seladelpar scores in Phase III cholangitis trial | The ...
#livercancer #liverawarenessmonth #liverdisease # ...
#easlcongress #primarybiliarycholangitis #liverdisease #hepatology # ...
Primary Biliary Cholangitis Pipeline Set For Major Breakthroughs By ...
#ddw2024 #primarybiliarycholangitis #liverdisease #hepatology # ...
#rarediseaseday #keeplearning #primarybiliarycholangitis #liverdisease ...
#throwbackthursday #juneteenth #pbc #liverdisease #raredisease # ...
Is Primary Biliary Cholangitis on Your Radar?
挑战百亿PBC市场！CymaBay发表Seladelpar的3期临床研究结果|氧胆酸|临床|研究|药物|-健康界
#ddw2024 #primarybiliarycholangitis #primarybiliarycholangitis # ...
#easl #easl2023 #easlcongress #liver #liverdisease #hepatology # ...
#pbc #primarybiliarycholangitis #patientresources #liverdisease # ...
Recent M&A News in Pharmaceuticals & Biotechnology Sector
Pharmaceutical Business Review International on LinkedIn: #acquisition ...
#career #hiring #vp #marketaccess #pbc #liverdisease #raredisease ...
#jobopportunity #hiring #biopharma #joinourteam #careergrowth # ...
By acquiring CymaBay, Gilead will gain a drug being developed for ...
#easlcongress #primarybiliarycholangitis #liverdisease #hepatology #pbc ...
#menshealthmonth #primarybiliarycholangitis #pbc #hepatology # ...
#tlm22 | Ed Cable
#iwd2024 #primarybiliarycholangitis #pbc #liverdisease #hepatology ...
#career #hiring #commercialcounsel #legal #pbc #liverdisease # ...
Gilead pays $4.3B for CymaBay, the biotech that never gave…
Pharma News | GSK, Gilead, CSL, CymaBay, Biogen, NovelMed
德国默克扩建上海生命科学技术与培训合作中心；吉利德完成收购CymaBay；艾伯维收购自身免疫初创公司Landos | 日报_中国_药物
Form 10-K
